Read
REG-Biocompatibles Intl.: Director/PDMR Shareholding
* Reuters is not responsible for the content in this press release.
30 July 2009
BIOCOMPATIBLES INTERNATIONAL PLC
(the `Company' or `Biocompatibles')
BIOCOMPATIBLES INTERNATIONAL PLC SHARE INCENTIVE PLAN
PURCHASE OF PARTNERSHIP SHARES AND AWARDS OF MATCHING SHARES
Biocompatibles International plc announces that on 30 July 2009 the following
executive directors purchased ordinary shares of 21 53/94 pence at a cost of
186.00 pence per share as "partnership shares" under the all-employee
Biocompatibles International Share Incentive Plan as summarised below:
Executive Director Number of shares acquired
Crispin Simon 68
Ian Ardill 68
Peter Stratford 68
John Sylvester 68
The above transactions were undertaken by the trustee of the Biocompatibles
International Share Incentive Plan, a UK registered company, on behalf of the
above individuals and the shares purchased on the London Stock Exchange.
In connection with the above purchases on the same date the executive directors
were conditionally awarded ordinary shares of 21 53/94 pence as "matching
shares" under the all employee Biocompatibles International Share Incentive
Plan as summarised below:
Executive Director Number of shares awarded as "matching
shares"
Crispin Simon 136
Ian Ardill 136
Peter Stratford 136
John Sylvester 136
The risk of forfeiture attached to the matching shares will normally be removed
on the third anniversary of allocation subject to continued employment and the
retention of the Partnership shares in connection with which they were awarded.
No consideration was paid by the grantees for the award of the matching shares
and no consideration is due on the release of on the matching shares.
The above notifications are made in accordance with DR 3.1.4R(1).
Biocompatibles International plc was notified by the above individuals of the
above transaction on 30 July 2009.
- ends -
Contact:
Biocompatibles Tel: +44 (0)1257 732732
Ian Ardill, Finance Director
Sari Evetts, Assistant Company Secretary
END
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters